학술논문
Phase 3 Study of Lenalidomide (LEN) Vs Placebo in Non-Transfusion Dependent (TD) Low Risk Del(5q) MDS Patients with Del(5q) — Preliminary Blinded Analysis of the European Sintra-REV Trial
Document Type
Article
Author
López Cadenas, Félix; Lumbreras, Eva; Xicoy, Blanca; Sanchez-Garcia, Joaquin; Fenaux, Pierre; Coll, Rosa; Slama, Borhane; Hernandez-Rivas, Jose Angel; Thepot, Sylvain; Bernal, Teresa; Arrizabalaga, Beatriz; Guerci, Agnès; Sanz, Guillermo; Bargay, Joan; Amigo, Maria Luz; de Paz, Raquel; Giagounidis, Aristoteles; Platzbecker, Uwe; Nomdedeu, Benet; Jourdan, Eric; Götze, Katharina S.; Arar, Ali; Hernández-Rivas, Jesús María; Del Cañizo, Consuelo; Díez-Campelo, María
Source
Blood; November 2018, Vol. 132 Issue: Supplement 1 p468-468, 1p
Subject
Language
ISSN
00064971; 15280020
Abstract
Platzbecker: Celgene: Research Funding. Götze:JAZZ Pharmaceuticals: Honoraria; Takeda: Honoraria, Other: Travel aid ASH 2017; Novartis: Honoraria; Celgene: Honoraria, Research Funding. Díez-Campelo:Celgene: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding, Speakers Bureau; Novartis: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding, Speakers Bureau.